AVTXVSCNTX• 7 Days (Normalized)
AVTX vs CNTX (Avalo Therapeutics Inc. vs Context Therapeutics Inc.)
Showing Closing Date Range from Sep, 10 to Sep, 17, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
AVTX Performance $16.69
-2.85%
Avalo Therapeutics Inc.
Normalized Baseline0.00%
CNTX Performance $0.38
+4.75%
Context Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin CNTX LEADS
-7.6%
CNTX outperforming by 7.60%
AVTXCNTX
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
AVTX CNTX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(6 dates)
| Date | AVTX Price | AVTX Gain (%) | CNTX Price | CNTX Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 17, 2026 | $16.69 | -2.85% | $0.38 | +4.75% | -7.60% |
| Sep 16, 2026 | $16.58 | -3.49% | $0.38 | +3.55% | -7.04% |
| Sep 15, 2026 | $16.07 | -6.46% | $0.36 | -0.55% | -5.91% |
| Sep 14, 2026 | $16.18 | -5.82% | $0.35 | -4.10% | -1.72% |
| Sep 11, 2026 | $16.12 | -6.17% | $0.35 | -4.37% | -1.80% |
| Sep 10, 2026 | $17.18 | +0.00% | $0.37 | +0.00% | +0.00% |